JIMOXY-CV 625 contains Amoxicillin Trihydrate 500 mg + Clavulanic Acid 125 mg, offering enhanced antibacterial coverage for selected susceptible bacterial infections. A strong and widely useful PCD Pharma Antibiotic portfolio product.
Susceptible bacterial infections.
Yes, as prescribed.
Take with food if advised to improve gastrointestinal tolerance. Complete the course and report severe diarrhea or allergic symptoms promptly.
Diarrhea, nausea, vomiting, abdominal discomfort, rash and headache may occur.
JIMOXY-CV 625: Amoxicillin inhibits bacterial cell-wall synthesis, while Clavulanic Acid inhibits certain beta-lactamases, enhancing activity against susceptible resistant organisms.
